FDA approval of new manufacturing process for Humira biosimilar.
Context
What happened: The U.S. FDA approved a new manufacturing process for Simlandi, Alvotech's biosimilar to Humira that it markets with Teva Pharmaceutical.
Why it matters: Alvotech shares spiked on Tuesday following the approval. Simlandi targets AbbVie's arthritis therapy Humira (adalimumab).